GRI Bio (GRI) Competitors $1.44 -0.01 (-0.69%) As of 07/3/2025 01:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock GRI vs. PHIO, BCDA, PHXM, AIMD, CSCI, TRIB, GLYC, NKGN, KPRX, and BTAIShould you be buying GRI Bio stock or one of its competitors? The main competitors of GRI Bio include Phio Pharmaceuticals (PHIO), BioCardia (BCDA), PHAXIAM Therapeutics (PHXM), Ainos (AIMD), COSCIENS Biopharma (CSCI), Trinity Biotech (TRIB), GlycoMimetics (GLYC), NKGen Biotech (NKGN), Kiora Pharmaceuticals (KPRX), and BioXcel Therapeutics (BTAI). These companies are all part of the "pharmaceutical products" industry. GRI Bio vs. Its Competitors Phio Pharmaceuticals BioCardia PHAXIAM Therapeutics Ainos COSCIENS Biopharma Trinity Biotech GlycoMimetics NKGen Biotech Kiora Pharmaceuticals BioXcel Therapeutics GRI Bio (NASDAQ:GRI) and Phio Pharmaceuticals (NASDAQ:PHIO) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, media sentiment, profitability, analyst recommendations, institutional ownership, dividends, valuation and risk. Do analysts rate GRI or PHIO? GRI Bio currently has a consensus price target of $22.00, indicating a potential upside of 1,427.78%. Phio Pharmaceuticals has a consensus price target of $14.00, indicating a potential upside of 475.18%. Given GRI Bio's higher possible upside, equities research analysts clearly believe GRI Bio is more favorable than Phio Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score GRI Bio 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Phio Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is GRI or PHIO more profitable? Phio Pharmaceuticals' return on equity of -105.65% beat GRI Bio's return on equity.Company Net Margins Return on Equity Return on Assets GRI BioN/A -275.15% -168.22% Phio Pharmaceuticals N/A -105.65%-89.19% Which has more volatility and risk, GRI or PHIO? GRI Bio has a beta of -1.62, indicating that its share price is 262% less volatile than the S&P 500. Comparatively, Phio Pharmaceuticals has a beta of 0.91, indicating that its share price is 9% less volatile than the S&P 500. Does the media prefer GRI or PHIO? In the previous week, GRI Bio had 3 more articles in the media than Phio Pharmaceuticals. MarketBeat recorded 3 mentions for GRI Bio and 0 mentions for Phio Pharmaceuticals. GRI Bio's average media sentiment score of 0.72 beat Phio Pharmaceuticals' score of 0.00 indicating that GRI Bio is being referred to more favorably in the media. Company Overall Sentiment GRI Bio Positive Phio Pharmaceuticals Neutral Do insiders and institutionals believe in GRI or PHIO? 34.0% of GRI Bio shares are owned by institutional investors. Comparatively, 57.3% of Phio Pharmaceuticals shares are owned by institutional investors. 0.1% of GRI Bio shares are owned by insiders. Comparatively, 0.6% of Phio Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has higher earnings and valuation, GRI or PHIO? Phio Pharmaceuticals is trading at a lower price-to-earnings ratio than GRI Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGRI BioN/AN/A-$8.21M-$11.56-0.12Phio PharmaceuticalsN/AN/A-$7.15M-$10.92-0.22 SummaryPhio Pharmaceuticals beats GRI Bio on 7 of the 12 factors compared between the two stocks. Get GRI Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for GRI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GRI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GRI vs. The Competition Export to ExcelMetricGRI BioMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.08M$2.92B$5.55B$9.05BDividend YieldN/A2.44%5.24%4.01%P/E Ratio-0.1221.5627.6120.23Price / SalesN/A278.31417.23118.52Price / CashN/A42.7336.8958.10Price / Book0.197.518.035.67Net Income-$8.21M-$55.14M$3.18B$249.21M7 Day Performance13.39%4.61%2.93%3.28%1 Month Performance0.70%4.72%3.75%5.55%1 Year Performance-94.60%5.92%35.20%21.09% GRI Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GRIGRI Bio3.4528 of 5 stars$1.44-0.7%$22.00+1,427.8%-94.7%$3.08MN/A-0.121PHIOPhio Pharmaceuticals2.2118 of 5 stars$2.18-4.0%$14.00+542.2%-53.4%$10.87MN/A-0.2010BCDABioCardia3.9913 of 5 stars$2.02-2.9%$25.00+1,137.6%-29.4%$10.77M$3K-0.8740News CoveragePositive NewsInsider TradeGap UpPHXMPHAXIAM TherapeuticsN/A$3.10flatN/AN/A$10.58M$32.66M0.0049AIMDAinos0.6135 of 5 stars$0.50-1.7%N/A-30.0%$10.49M$20K-0.3940CSCICOSCIENS BiopharmaN/A$3.36+1.8%N/AN/A$10.38M$9.59M-0.5820Gap DownTRIBTrinity Biotech0.382 of 5 stars$0.55-2.6%N/A-66.9%$10.25M$61.56M-0.20480News CoverageGap UpGLYCGlycoMimetics1.1705 of 5 stars$0.16-6.6%N/A-99.4%$10.00M$10K-0.3450High Trading VolumeNKGNNKGen BiotechN/A$0.22-11.0%N/A-77.1%$10.00M$80K-0.04N/AKPRXKiora Pharmaceuticals2.3167 of 5 stars$3.13-2.2%$10.00+219.5%-33.7%$9.74M$16.02M-1.0810BTAIBioXcel Therapeutics4.5094 of 5 stars$1.65+3.1%$42.60+2,481.8%-88.7%$9.69M$2.27M-0.1290Gap Up Related Companies and Tools Related Companies PHIO Alternatives BCDA Alternatives PHXM Alternatives AIMD Alternatives CSCI Alternatives TRIB Alternatives GLYC Alternatives NKGN Alternatives KPRX Alternatives BTAI Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GRI) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GRI Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GRI Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GRI Stock Alerts